(Q43503625)

24 November 2017

title

Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria (English)

1 reference

24 November 2017

1 reference

Nelson HS

1

1 reference

24 November 2017

Reynolds R

series ordinal

2

1 reference

24 November 2017

Mason J

series ordinal

3

1 reference

24 November 2017

publication date

1 May 2000

1 reference

Annals of Allergy, Asthma & Immunology

24 November 2017

published in

1 reference

24 November 2017

volume

84

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

517-522

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

24 November 2017

1 reference

7 January 2021

Update on urticaria and angioedema (hives).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

The pathogenesis of chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

ABC of allergies. Allergy and the skin. I--Urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

Urticaria: current therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

Histamine: the quintessential mediator

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

H1-receptor antagonists. Comparative tolerability and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

Peripheral H1-blockade effect of fexofenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

The validity and reproducibility of a work productivity and activity impairment instrument

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

Cardiovascular safety of fexofenadine HCl.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962515-X

7 January 2021

10.1016/S1081-1206(10)62515-X

Identifiers

DOI

1 reference

24 November 2017

1 reference